Helmerich & Payne, Inc. (NYSE:HP) Shares Sold by Physicians Financial Services Inc.

Physicians Financial Services Inc. lowered its stake in shares of Helmerich & Payne, Inc. (NYSE:HP) by 13.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,680 shares of the oil and gas company’s stock after selling 1,400 shares during the quarter. Physicians Financial Services Inc.’s holdings in Helmerich & Payne were worth $416,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Capital International Ltd. CA raised its position in Helmerich & Payne by 172.0% during the third quarter. Capital International Ltd. CA now owns 20,400 shares of the oil and gas company’s stock valued at $1,403,000 after buying an additional 12,900 shares during the period. Highland Capital Management LLC purchased a new position in Helmerich & Payne in the fourth quarter valued at about $4,212,000. Verity Asset Management Inc. purchased a new position in Helmerich & Payne in the third quarter valued at about $329,000. AMP Capital Investors Ltd grew its stake in Helmerich & Payne by 107.7% in the third quarter. AMP Capital Investors Ltd now owns 67,640 shares of the oil and gas company’s stock valued at $4,674,000 after purchasing an additional 35,067 shares in the last quarter. Finally, BTIM Corp. boosted its stake in shares of Helmerich & Payne by 3.5% during the 3rd quarter. BTIM Corp. now owns 200,462 shares of the oil and gas company’s stock worth $13,786,000 after acquiring an additional 6,711 shares in the last quarter. Institutional investors and hedge funds own 91.43% of the company’s stock.

HP opened at $56.50 on Thursday. Helmerich & Payne, Inc. has a 1 year low of $44.56 and a 1 year high of $74.36. The stock has a market capitalization of $6.07 billion, a price-to-earnings ratio of 403.57 and a beta of 1.57. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.29 and a current ratio of 2.70.

Helmerich & Payne (NYSE:HP) last released its earnings results on Tuesday, January 29th. The oil and gas company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.14. The business had revenue of $740.60 million for the quarter, compared to the consensus estimate of $716.12 million. Helmerich & Payne had a return on equity of 1.18% and a net margin of 0.06%. On average, analysts expect that Helmerich & Payne, Inc. will post 1.61 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 1st. Investors of record on Friday, February 8th will be given a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 5.03%. The ex-dividend date of this dividend is Thursday, February 7th. Helmerich & Payne’s dividend payout ratio is currently 2,028.57%.

In other news, VP John R. Bell sold 13,000 shares of the business’s stock in a transaction that occurred on Monday, November 26th. The stock was sold at an average price of $60.17, for a total transaction of $782,210.00. Following the completion of the sale, the vice president now owns 63,375 shares in the company, valued at $3,813,273.75. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Michael Lennox sold 6,912 shares of Helmerich & Payne stock in a transaction that occurred on Tuesday, December 11th. The shares were sold at an average price of $60.08, for a total transaction of $415,272.96. Following the completion of the sale, the vice president now owns 10,360 shares of the company’s stock, valued at $622,428.80. The disclosure for this sale can be found here. Company insiders own 4.17% of the company’s stock.

Several analysts have recently issued reports on the company. Bank of America began coverage on Helmerich & Payne in a research note on Wednesday, October 17th. They set an “underperform” rating for the company. BMO Capital Markets restated a “sell” rating and set a $62.00 price target on shares of Helmerich & Payne in a research report on Sunday, October 21st. ValuEngine upgraded Helmerich & Payne from a “hold” rating to a “buy” rating in a research report on Tuesday, November 20th. Credit Suisse Group upgraded Helmerich & Payne from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $63.00 to $65.00 in a research report on Monday, November 19th. Finally, SunTrust Banks upgraded Helmerich & Payne from a “sell” rating to a “buy” rating and increased their price objective for the company from $58.00 to $75.00 in a research report on Monday, November 19th. Four analysts have rated the stock with a sell rating, six have given a hold rating and twelve have issued a buy rating to the company. Helmerich & Payne has a consensus rating of “Hold” and a consensus target price of $67.11.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/02/14/helmerich-payne-inc-hp-position-reduced-by-physicians-financial-services-inc.html.

Helmerich & Payne Company Profile

Helmerich & Payne, Inc primarily engages in drilling oil and gas wells for exploration and production companies. The company operates through U.S. Land, Offshore, and International Land segments. The U.S. Land segment drills primarily in Colorado, Louisiana, Ohio, Oklahoma, New Mexico, North Dakota, Pennsylvania, Texas, Utah, West Virginia, and Wyoming.

Featured Story: How Short Selling Works

Institutional Ownership by Quarter for Helmerich & Payne (NYSE:HP)

Receive News & Ratings for Helmerich & Payne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helmerich & Payne and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply